Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Geneos Therapeutics, a clinical-stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines […]
Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment
Shanghai Junshi Biosciences (TopAlliance), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and […]
Treventis Partners its Preclinical Program in Alzheimer's Disease with Takeda
Treventis Corporation, a privately held biotechnology company, announced today that it has entered an option, […]
Glooko Announces Partnership with Insulin Dosing Algorithm Company Hedia
Glooko announced today a new Global partnership with Hedia, integrating its technology into Glooko’s diabetes […]
Ultima Genomics and Genome Insight Collaborate to Bring Affordable Whole Genome Sequencing to Cancer Patients
Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole […]
Life-Saving NHS Test Helping To Diagnose Thousands With Cancer-Causing Syndrome
A life-saving NHS testing programme is helping to diagnose thousands of people with a genetic […]
NIH Awards $4.7M to Cohen Children’s Medical Center and The Feinstein Institutes to Study Nephrotic Syndrome in Children
The National Institutes of Health (NIH) has awarded Northwell Health’s Cohen Children’s Medical Center and […]
MOLLI Surgical Launches Breakthrough Products to Simplify Breast Cancer Surgery and Deliver a Better Patient Experience
MOLLI Surgical, the company that is pushing the boundaries of precision surgery for breast cancer, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more